Nicotinic acid in the treatment of schizophrenia.
D000208:Acute Disease; D001786:Blood Glucose / Q000032:analysis; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D008297:Male; D009536:Niacinamide / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000139:chemically induced; D010919:Placebos; D011537:Pruritus / Q000139:chemically induced; D012559:Schizophrenia / Q000188:drug therapy*; D013997:Time Factors
D001786:Blood Glucose; D009539:Nicotinic Acids; D010919:Placebos; D009536:Niacinamide